Stockreport

Nuvation Bio falls after AnHeart Therapeutics acquisition news [Seeking Alpha]

Nuvation Bio Inc. Class A  (NUVB) 
PDF AnHeart Therapeutics is a clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer. Nuvation Bio will issue ~43.6M class A [Read more]